Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

55.89
Delayed Data
As of Mar 24
 +0.12 / +0.22%
Today’s Change
46.01
Today|||52-Week Range
77.12
-4.36%
Year-to-Date
Pharma Stock Roundup: Is Sanofi Buying Flexion? Pfizer, Merck KGaA Drug Approved
Mar 24 / Zacks.com - Paid Partner Content
Dow, Nasdaq Rise as FBI's Comey Confirms Probe of Russia's Election Interference
Mar 20 / TheStreet.com - Paid Partner Content
Merck KGaA Shares Spike After FDA Approves Skin Cancer Treatment
Mar 24 / TheStreet.com - Paid Partner Content
Celldex (CLDX) Shares Up as Q4 Loss Narrows; Sales Beat
Mar 15 / Zacks.com - Paid Partner Content
After Snap IPO, SEC Nominee Sees Change in Power Balance
Mar 23 / TheStreet.com - Paid Partner Content
Celldex Therapeutics, Inc. Ends Q4 With Plenty of Cash and Several Key Studies Progre...
Mar 14 / MotleyFool.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Why Lantheus Holdings Inc. Got Smacked Down Today
Mar 14 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb and CytomX Therapeutics Extend Deal
Mar 21 / Zacks.com - Paid Partner Content
The 3 Most Important Numbers for Exelixis, Inc.
Mar 14 / MotleyFool.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content
3 Big Pharma Stocks To Buy in Your 401(k)
Mar 12 / MotleyFool.com - Paid Partner Content
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic PLC, Se...
Mar 20 / GuruFocus News - Paid Partner Content
Trump vows to bring drug prices 'way down'
Mar 07 / CNNMoney.com
Stocks Lower as Crude Slump Weighs on Energy Sector
Mar 20 / TheStreet.com - Paid Partner Content